Ocular Therapeutix, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OCUL research report →
About the company
Ocular Therapeutix, Inc. is a biopharmaceutical company specializing in the creation, advancement, and commercialization of ophthalmic treatments. Their innovative approach leverages a proprietary bioresorbable hydrogel technology to address a range of eye diseases and conditions.
- CEO
- Pravin U. Dugel
- IPO
- 2014
- Employees
- 274
- HQ
- Bedford, MA, US
Price Chart
- Market Cap
- $2.11B
- P/E
- -6.60
- P/S
- 40.56
- P/B
- 3.71
- EV/EBITDA
- -5.56
- Div Yield
- 0.00%
- Gross Margin
- 87.24%
- Op Margin
- -575.42%
- Net Margin
- -558.24%
- ROE
- -64.55%
- ROIC
- -43.52%
- Revenue
- $51.82M · -18.67%
- Net Income
- $-265,939,000 · -37.43%
- EPS
- $-1.42 · -16.39%
- Op Income
- $-270,017,000
- FCF YoY
- -59.52%
- 52W High
- $16.44
- 52W Low
- $6.23
- 50D MA
- $9.15
- 200D MA
- $10.38
- Beta
- 0.88
- Avg Volume
- 3.03M
Get TickerSpark's AI analysis on OCUL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 16, 26 | Dugel Pravin | other | 50,092 |
| Jun 16, 26 | Dugel Pravin | other | 50,092 |
| Jun 10, 26 | Warden Charles M | other | 14,000 |
| Jun 10, 26 | Warden Charles M | other | 44,000 |
| Jun 10, 26 | Graves Adrienne L | other | 14,000 |
| Jun 10, 26 | Graves Adrienne L | other | 44,000 |
| Jun 10, 26 | Robins Jason Shand | other | 15,441 |
| Jun 10, 26 | Robins Jason Shand | other | 14,024 |
| Jun 10, 26 | Hong Seung Suh | other | 14,000 |
| Jun 10, 26 | Hong Seung Suh | other | 44,000 |
Our OCUL coverage
Recent articles, reports, and earnings notes.
No research on OCUL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OCUL report →Similar companies
Peers in the same neighborhood.